Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1566174

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1566174

Neuroprosthetics Market Size, Share, Growth Analysis, By Type, By Technique, By Application, By Region - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Neuroprosthetics Market size was valued at USD 10.3 billion in 2022 and is poised to grow from USD 11.59 billion in 2023 to USD 29.73 billion by 2031, growing at a CAGR of 12.50% during the forecast period (2024-2031).

The rising prevalence of neurological disorders and the growing demand for cost-effective, technologically advanced implants are anticipated to drive the growth of the global neuroprosthetics market in the coming years. Additionally, the increasing geriatric population and the growing incidence of diseases such as auditory disorders, epilepsy, Alzheimer's, and severe depression are further contributing to the market's expansion. As the need for improved treatments grows, the demand for neuroprosthetic solutions is expected to rise globally. The significant increase in hearing loss cases also plays a key role in market growth. Devices like hearing aids and cochlear implants are crucial in addressing these issues. According to the World Health Organization, by 2031, approximately 2.5 billion people worldwide are projected to suffer from hearing loss, with around 700 million expected to require hearing rehabilitation. This growing burden of hearing impairment is likely to further boost demand for neuroprosthetics in the near future. Technological advancements and increased investment in research and development by major companies and government organizations are also expected to fuel market growth. For example, in August 2019, MED-EL received approval from the U.S. Food & Drug Administration for its Synchrony-2 Cochlear Implant System, designed for patients with single-sided deafness and asymmetric hearing loss, illustrating the continuous innovation driving the sector forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neuroprosthetics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neuroprosthetics Market Segmental Analysis

Global Neuroprosthetics Market is segmented by Type, Technique, Application, and region. Based on Type, the market is segmented into Output Neural Prosthetics, Neural Prosthetic. Based on Technique, the market is segmented into Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Transcranial Magnetic Stimulation. Based on Application, the market is segmented into Motor Neuron Disorders, Physiological Disorders, and Cognitive Disorders. Based on end user, the market is segmented into automotive, consumer electronics, healthcare, agriculture, manufacturing, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Neuroprosthetics Market

The high prevalence of neurological disorders and nerve-related injuries is expected to be a significant driver for the global neuroprosthetics market during the forecast period. For instance, neurological diseases have led to more than 533,000 deaths, with around 213,000 males and 320,000 females affected. Neuroprosthetic devices offer numerous benefits, making them essential in the treatment of such conditions. These devices, such as cochlear implants and auditory brainstem implants (ABI), are particularly beneficial for patients with hearing impairments. As a result, the global demand for neuroprosthetics in diagnosing and treating various neurological disorders is expected to fuel market growth in the coming years. The increasing recognition of the advantages of these devices in improving patient outcomes will likely lead to greater adoption, further propelling the market's expansion.

Restraints in the Global Neuroprosthetics Market

The growing popularity of alternative treatment methods, such as stem cell therapy, is expected to significantly hamper the growth of the neuroprosthetics market during the forecast period. Stem cell therapy provides promising opportunities for treating various neurological conditions, including motor neuron diseases like Parkinson's and Alzheimer's. Its appeal lies in its relatively lower cost compared to neuroprosthetic devices, as well as the simplicity of its treatment regimen, which is attracting more patients toward this alternative option. As a result, the increasing shift toward stem cell treatments is likely to restrain the global expansion of the neuroprosthetics market in the coming years, as patients opt for these cost-effective and less invasive alternatives.

Market Trends of the Global Neuroprosthetics Market

Input neural prosthetics are gaining increasing popularity due to the rising prevalence of hearing loss and technological advancements in the development of various devices. These prosthetics offer significant benefits, such as restoring a sense of sound for individuals who are profoundly deaf or hard of hearing. Their ease of use and relatively low implementation cost make them attractive, creating substantial growth opportunities in the coming years. Research indicates that cochlear implants not only help diagnose hearing loss but are also being recommended as a rehabilitation tool for tinnitus patients suffering from depression. As a result, the neuroprosthetics market is poised for significant growth in the near future, driven by the growing demand for innovative solutions to address hearing loss and other related conditions.

Product Code: SQMIG35A2517

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Technology Analysis
  • Regulatory Analysis
  • Case Study Analysis

Neuroprosthetics Market by Type

  • Market Overview
  • Output Neural Prosthetics
    • Motor Prosthetics
    • Cognitive Prosthetics
  • Input Neural Prosthetics
    • Cochlear Implants
    • Bionic Eye/Retinal Implants

Neuroprosthetics Market by Technique

  • Market Overview
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Vagus Nerve Stimulation
  • Sacral Nerve Stimulation
  • Transcranial Magnetic Stimulation

Neuroprosthetics Market by Application

  • Market Overview
  • Motor Neuron Disorders
    • Parkinson'S Disease
    • Epilepsy
  • Physiological Disorders
    • Auditory Processing Disorders
    • Ophthalmic Disorders
    • Cardiovascular Disorders
    • Urology Disorders
  • Cognitive Disorders
    • Alzheimer'S Disease
    • Paralysis

Neuroprosthetics Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Medtronic (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cochlear (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Livanova (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Med-El (Austria)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sonova (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neuropace (U S)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NDI Medical (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nevro (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SensArs Neuroprosthetics (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NeuroPace, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pixium Vision (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NeuroSigma, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Axonics Modulation Technologies, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nervo Corp (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Soterix Medical, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aleva Neurotherapeutics SA (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Synapse Biomedical, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cleveland FES Center (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!